Swiss recall Zelnorm equivalent

Following a Zelnorm recall in the United States on March 30 2007, Swiss pharmaceutical regulators announced last week that they have ordered the manufacturer, Novartis AG, to remove the foreign equivalent, Zelmac, from the market.  Swissmedic, the country’s regulatory agency, determined that the risk of heart… Read More

Austin Kirk

By
June 4, 2007 | No Comments

OxyContin lawsuits still being reviewed nationwide

UPDATE 9/4/2007: Saiontz & Kirk is no longer reviewing potential new OxyContin lawsuits.  Earlier this month, a criminal investigation concluded with the makers of OxyContin pleading guilty to misdemeanor violations of misbranding the drug by actively minimizing the risk of addiction to increase profits, even at the… Read More

Harvey Kirk

By
May 30, 2007 | 5 Comments

Complete Moisture Plus Recall Lawsuits

Following reports from the CDC of an increased risk of a serious and potentially blinding eye infections, AMO Complete Moisture Plus multi purpose lens solution has been removed from the market.  The lawyers at Saiontz & Kirk are reviewing Complete Moisture Plus recall lawsuits nationwide. >>INFORMATION:… Read More

Austin Kirk

By
May 27, 2007 | 5 Comments

MRI Contrast Problems lead to FDA warning

Today the FDA requested that a black box warning be added to MRI contrast agents which are gadolinium-based.  For those with kidney problems, an MRA or MRI with contrast could lead to a debilitating and potentially fatal condition known as nephrogenic systemic fibrosis (NSF).  Problems with… Read More

Austin Kirk

By
May 23, 2007 | 7 Comments

Exjade kidney problems leads to FDA warning

The FDA and drug maker Novartis AG have issued an important warning about problems with Exjade which could lead to kidney failure or death.  Information about Exjade side effects were outlined in a May 14, 2007 letter to healthcare providers which was posted on the FDA… Read More

Harvey Kirk

By
May 22, 2007 | 3 Comments